NasdaqCM - Nasdaq Real Time Price USD

Ocugen, Inc. (OCGN)

Compare
0.8574 +0.0050 (+0.59%)
At close: December 13 at 4:00:01 PM EST
0.8698 +0.01 (+1.45%)
After hours: 7:58:38 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,700.0000
6,036.0000
2,488.0000
--
43.0000
Operating Expense
57,142.0000
71,567.0000
91,559.0000
58,028.0000
14,328.0000
Operating Income
-52,442.0000
-65,531.0000
-89,071.0000
-58,028.0000
-14,285.0000
Net Non Operating Interest Income Expense
--
--
--
-79.0000
-721.0000
Other Income Expense
1,298.0000
2,453.0000
2,267.0000
-389.0000
-6,816.0000
Pretax Income
-51,144.0000
-63,078.0000
-86,804.0000
-58,417.0000
-21,822.0000
Tax Provision
--
--
--
-52.0000
--
Net Income Common Stockholders
-51,144.0000
-63,078.0000
-86,804.0000
-58,365.0000
-34,368.0000
Diluted NI Available to Com Stockholders
-51,144.0000
-63,078.0000
-86,804.0000
-58,365.0000
-34,368.0000
Basic EPS
-0.19
-0.26
-0.38
-0.30
-0.31
Diluted EPS
-0.19
-0.26
-0.38
-0.30
-0.31
Basic Average Shares
262,387.6770
244,327.0570
214,600.0510
195,013.0430
112,236.1100
Diluted Average Shares
262,387.6770
244,327.0570
214,600.0510
195,013.0430
112,236.1100
Total Operating Income as Reported
-52,442.0000
-65,531.0000
-89,071.0000
-58,028.0000
-21,285.0000
Total Expenses
57,142.0000
71,567.0000
91,559.0000
58,028.0000
14,328.0000
Net Income from Continuing & Discontinued Operation
-51,144.0000
-63,078.0000
-86,804.0000
-58,365.0000
-21,822.0000
Normalized Income
-51,144.0000
-63,078.0000
-86,804.0000
-58,365.0000
-14,822.0000
Interest Income
--
--
--
--
1.0650
Interest Expense
--
--
--
79.0000
721.0000
Net Interest Income
--
--
--
-79.0000
-721.0000
EBIT
-52,442.0000
-65,531.0000
-89,071.0000
-58,028.0000
-21,101.0000
EBITDA
-50,893.0000
-64,827.0000
-88,591.0000
-57,799.0000
-20,999.0000
Reconciled Depreciation
1,549.0000
704.0000
480.0000
229.0000
102.0000
Net Income from Continuing Operation Net Minority Interest
-51,144.0000
-63,078.0000
-86,804.0000
-58,365.0000
-21,822.0000
Total Unusual Items Excluding Goodwill
--
--
--
--
-7,000.0000
Total Unusual Items
--
--
--
--
-7,000.0000
Normalized EBITDA
-50,893.0000
-64,827.0000
-88,591.0000
-57,799.0000
-13,999.0000
Tax Rate for Calcs
--
--
--
0.0000
--
12/31/2020 - 12/3/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VXRT Vaxart, Inc.
0.5920
-0.75%
 
TNXP Tonix Pharmaceuticals Holding Corp.
0.2405
+5.07%
 
JAGX Jaguar Health, Inc.
0.9693
-0.59%
 
INO Inovio Pharmaceuticals, Inc.
2.3200
-38.30%
 
CDIO Cardio Diagnostics Holdings, Inc.
1.2600
+5.00%
 
SAVA Cassava Sciences, Inc.
2.7500
-1.43%
 
BIOR Biora Therapeutics, Inc.
0.5597
0.00%
 
NVAX Novavax, Inc.
9.11
+1.00%
 
IBIO iBio, Inc.
2.3100
-7.97%
 
ATOS Atossa Therapeutics, Inc.
1.1200
-2.61%